LDN 2019 Conference - Saturday Afternoon Q&A (2019 Conference) (LDN, low dose naltrexone)

Presentations on the below and questions were asked in relation to:

Pamela Smith, MD - LDN Use in Cognitive Decline, Lyme Disease, and Hashimoto’s Thyroiditis (2019 Conference) (LDN, low dose naltrexone)

Michael Ruscio, DC - The Gut-Thyroid Connection, Profound but Under-Appreciated (2019 Conference) (LDN, low dose naltrexone)

Elissa Mullen, ND - Sleep - PTSD HPA Axis Dysregulation - LDN & The Gut Brain Barrier (2019 Conference) (LDN, low dose naltrexone)

She describes sleep dysregulation and presents patient cases and relevant research.

Dana Keaton, ND - The scope of patient selection for LDN (2019 Conference) (LDN, low dose naltrexone)

Dr John Kim, LDN Radio Show 2016 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Linda Elsegood: Today I'm joined by Dr. John Kim from Georgia Integrative Medicine Clinic in the US. Thank you for joining us today. 

The Remarkable Benefits of Low-Dose Naltrexone

Martha - US: Fibromyalgia (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Martha is from Hawaii in the United States, and takes low dose naltrexone (LDN) for fibromyalgia. Her first symptoms were a series of mysterious illnesses, stomach problems, fatigue, multiple chemical sensitivities, that in  2010 was diagnosed as fibromyalgia.

Margaret - US: Cushing's, Hashimoto's, PCOS, Arthritis, Depression (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Linda Elsegood: I'd like to introduce Margaret from the United States who takes LDN. Thank you for joining me, Margaret.

Margaret: Hi,

Manda - Holland: Hashimoto's Thyroiditis (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.